Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2012 1
2013 3
2014 1
2016 1
2019 1
2021 1
2022 3
2023 4
2024 3
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Updates on eosinophilic disorders.
Tzankov A, Reichard KK, Hasserjian RP, Arber DA, Orazi A, Wang SA. Tzankov A, et al. Virchows Arch. 2023 Jan;482(1):85-97. doi: 10.1007/s00428-022-03402-8. Epub 2022 Sep 7. Virchows Arch. 2023. PMID: 36068374 Review.
This review addresses changes and updates in eosinophilic disorders under the International Consensus Classification (ICC). The previous category of myeloid/lymphoid neoplasm with eosinophilia (M/LN-eo) and a specific gene rearrangement is changed to M/LN-eo with tyrosine …
This review addresses changes and updates in eosinophilic disorders under the International Consensus Classification (ICC). The previ …
The international consensus classification of eosinophilic disorders and systemic mastocytosis.
Wang SA, Orazi A, Gotlib J, Reiter A, Tzankov A, Hasserjian RP, Arber DA, Tefferi A. Wang SA, et al. Am J Hematol. 2023 Aug;98(8):1286-1306. doi: 10.1002/ajh.26966. Epub 2023 Jun 7. Am J Hematol. 2023. PMID: 37283522 Free article. Review.
The category has been expanded to include ETV6::ABL1 and FLT3 fusions, and to accept PCM1::JAK2 and its genetic variants as formal members. ...The major diagnostic criteria for systemic mastocytosis (SM) in the ICC remain largely based on morphology, but several min …
The category has been expanded to include ETV6::ABL1 and FLT3 fusions, and to accept PCM1::JAK2 and its genetic variants as fo …
Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia.
Xue S, Sun HP, Huang XB, Chen X, Wang T, Ma W, Tian Y, Pan ZL, Li LH, Zhang L, Liu HX, Cao XY. Xue S, et al. Int J Hematol. 2024 May;119(5):564-572. doi: 10.1007/s12185-024-03729-9. Epub 2024 Mar 5. Int J Hematol. 2024. PMID: 38441775 Review.
OBJECTIVE: To describe the features of ETV6::ABL1 AML as well as the clinical treatment and outcomes. METHODS: Clinical data were collected from three patients diagnosed with ETV6::ABL1 AML at Hebei Yanda Lu Daopei Hospital and Beijing Lu Daopei Hospit …
OBJECTIVE: To describe the features of ETV6::ABL1 AML as well as the clinical treatment and outcomes. METHODS: Clinical data w …
A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature.
Tirado CA, Siangchin K, Shabsovich DS, Sharifian M, Schiller G. Tirado CA, et al. Biomark Res. 2016 Aug 25;4(1):16. doi: 10.1186/s40364-016-0070-7. eCollection 2016. Biomark Res. 2016. PMID: 27570624 Free PMC article.
BACKGROUND: Acute myeloid leukemia (AML) is commonly characterized by several chromosomal abnormalities resulting in the formation of chimeric genes that play various roles in leukemogenesis. Translocations resulting in the ETV6-ABL1 fusion gene are rare in AML and …
BACKGROUND: Acute myeloid leukemia (AML) is commonly characterized by several chromosomal abnormalities resulting in the formation of chimer …
T cell phenotype and lack of eosinophilia are not uncommon in extramedullary myeloid/lymphoid neoplasms with ETV6::FLT3 fusion: a case report and review of the literature.
Schoelinck J, Gervasoni J, Guillermin Y, Beillard E, Pissaloux D, Chassagne-Clement C. Schoelinck J, et al. Virchows Arch. 2024 May;484(5):853-857. doi: 10.1007/s00428-023-03693-5. Epub 2023 Nov 20. Virchows Arch. 2024. PMID: 37985498 Review.
In the 2022, WHO and ICC classifications, myeloid/lymphoid neoplasms with eosinophilia (M/LN-eo) and tyrosine kinase gene fusions represent rare hematologic malignancies driven by rearrangements of PDGFRA, PDGFRB, FGFR1, JAK2, FLT3, and ETV6::ABL1 fusion. Eosinophil …
In the 2022, WHO and ICC classifications, myeloid/lymphoid neoplasms with eosinophilia (M/LN-eo) and tyrosine kinase gene fusions represent …
Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review.
Gancheva K, Virchis A, Howard-Reeves J, Cross NC, Brazma D, Grace C, Kotzampaltiris P, Partheniou F, Nacheva E. Gancheva K, et al. Mol Cytogenet. 2013 Sep 20;6(1):39. doi: 10.1186/1755-8166-6-39. Mol Cytogenet. 2013. PMID: 24053143 Free PMC article.
In addition, we confirm the association of the ETV6-ABL1 fusion with imatinib resistance reported so far in three other patients, while recording excellent response to the 2nd generation tyrosine kinase inhibitor (TKI) nilotinib. In summary, we highlight the value o …
In addition, we confirm the association of the ETV6-ABL1 fusion with imatinib resistance reported so far in three other patien …
Eosinophilia in acute myeloid leukemia: Overlooked and underexamined.
Naymagon L, Marcellino B, Mascarenhas J. Naymagon L, et al. Blood Rev. 2019 Jul;36:23-31. doi: 10.1016/j.blre.2019.03.007. Epub 2019 Mar 30. Blood Rev. 2019. PMID: 30948162 Review.
The presence of eosinophilia in acute myeloid leukemia (AML) suggests an underlying core binding factor (CBF) lesion, a platelet derived growth factor (PDGFR) translocation, or another rare translocation (such as ETV6-ABL1). Each of these cytogenetic entities carrie …
The presence of eosinophilia in acute myeloid leukemia (AML) suggests an underlying core binding factor (CBF) lesion, a platelet derived gro …
Mixed-phenotype (B-lymphocytic/myeloid) acute leukemia with ETV6-ABL1 expression.
Wang L, He D, Lu L, Wang H, Wang S. Wang L, et al. Pak J Med Sci. 2024 Jul;40(6):1294-1299. doi: 10.12669/pjms.40.6.8497. Pak J Med Sci. 2024. PMID: 38952502 Free PMC article. Review.
Positivity of both MPAL and ETV6-ABL1 suggest a poor prognosis. This is the first report of B lymphocytic/myeloid mixed-phenotype acute leukemia with ETV6-ABL1 fusion gene positivity. ...There are 126 cases of ETV6-ABL1 fusion gene transc …
Positivity of both MPAL and ETV6-ABL1 suggest a poor prognosis. This is the first report of B lymphocytic/myeloid mixed-phenot …
How I diagnose and treat myeloid/lymphoid neoplasms with tyrosine kinase gene fusions.
Reiter A, Metzgeroth G, Cross NCP. Reiter A, et al. Blood. 2025 Apr 17;145(16):1758-1768. doi: 10.1182/blood.2023022417. Blood. 2025. PMID: 39046810 Review.
Because primary/secondary BP-BM/EMD occurs more frequently in MLN-FGFR1/JAK2/FLT3/ETV6::ABL1, a sequential combination of selective TKIs with or without prior intensive chemotherapy, rarely local radiotherapy, and/or subsequent allogeneic hematopoietic cell transpla …
Because primary/secondary BP-BM/EMD occurs more frequently in MLN-FGFR1/JAK2/FLT3/ETV6::ABL1, a sequential combination of sele …
ABL1 fusion genes in hematological malignancies: a review.
De Braekeleer E, Douet-Guilbert N, Rowe D, Bown N, Morel F, Berthou C, Férec C, De Braekeleer M. De Braekeleer E, et al. Eur J Haematol. 2011 May;86(5):361-71. doi: 10.1111/j.1600-0609.2011.01586.x. Epub 2011 Mar 23. Eur J Haematol. 2011. PMID: 21435002 Review.
Fusion genes that have a break in intron 1 or 2 (BCR-ABL1, ETV6-ABL1, ZMIZ1-ABL1, EML1-ABL1, and NUP214-ABL1) have transforming activity, although NUP214-ABL1 requires amplification to be efficient. ...
Fusion genes that have a break in intron 1 or 2 (BCR-ABL1, ETV6-ABL1, ZMIZ1-ABL1, EML1-ABL1, and NUP214-ABL1) have transformin …
18 results